fatnews.com Fatnews Bitchute Channel Link Home page  >  Article | Previous article | Next article



  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Low cholesterol levels are dangerous, high ones usually are not, Joel Kauffman, PhD

    Posted by .(JavaScript must be enabled to view this email address)
    Thursday, November 03, 2011 12:14 pm Email this article
    The basis for using cholesterol-lowering drugs is not based on science notes Joel M. Kauffman, PhD, the author of Malignant Medical Myths: Why Medical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself.

    "Low cholesterol levels are dangerous; high ones usually are not," Kauffman writes. Cholesterol Levels Increase Naturally With Age

    Cholesterol levels increase naturally with age probably to protect us

    “Cholesterol levels increase naturally with age, probably as a defense mechanism against inflammation and cancer.


    Statins of Little Benefit

    Statins of little benefit, but have debilitating side effects

    “Clinical trials (RCTs) of statin drugs indicate no worthwhile overall benefit for primary prevention of heart attacks, but high risk of debilitating side-effects.

    “Trials on secondary prevention [ that is, involving people who have already had a heart attack] indicate very minor benefits on the order of what might have been obtained from Bufferin [aspirin to prevent a second heart attack], and the benefits are unrelated to the achieved cholesterol levels.


    Any Benefit of Statins Has Nothing to Do with Lowering Cholesterol

    Any benefit of statins has nothing to do with lowering cholesterol

    “In hospitalized men with [cardiovascular disease]... the minor benefits of statin drugs have nothing to do with lowering serum cholesterol levels.


    Statins Provide Little Benefit in Men, and NO Benefit in Women

    Statins provide little benefit in men, and NO benefit in women

    “It is unlikely that the adverse-effect-prone statin drugs are of any overall benefit in men, and certainly not in women.


    There Is No Reason To Lower Cholesterol

    There is no reason to lower cholesterol with drugs or alternative treatments

    “Any hype for alternative cholesterol-lowering treatments indicates a complete fraud since there is no reason for lowering cholesterol levels.”


    Kauffman’s Journey Began in 1999

    In 1999, Kauffman’s started researching the truth about aspirin

    Kauffman notes that:

    “Beginning in 1999 the conflict between recommendations on long-term use of aspirin to prevent heart attacks was so striking that I dug into the medical journals to find out the truth about aspirin.

    “The result became Myth One in my book Malignant Medical Myths: Why Medical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself.


    Until 1990, Kauffman Believed the Medical Literature and Diet Advice

    Until 1990, Kauffman believed the medical literature and diet advice, believing that most medical and diet advice was reliable

    Early, Kaufmann noted that:

    “Until about 1990, like most people, Kauffman believed that most medical and diet advice was reliable, especially from government agencies we pay so much to take care of us.


    Until 1990, Kauffman Took a Baby Aspirin, Had is Cholesterol Measured, Etc

    Until 1990, Kauffman took a baby aspirin, had is cholesterol measured, drank fluoridated water, etc, believing that medical journal articles were honest and complete

    “He took baby aspirin, ate trans fat, drank fluoridated water and had his cholesterol measured in the belief that others were looking out for us by basing their recommendations on the best evidence from trials.

    “When medical brochures and advertisements referred to papers in peer-reviewed medical journals, I assumed that these papers were honest and complete, based on my own experience as the author of 80 journal papers myself, which were subject to rigorous peer review.


    Medical Abstracts Often Incomplete and Misleading

    Kauffman found that medical abstracts were often incomplete and misleading, often leaving out all-cause mortality and side-effects

    Kauffman goes on to say:

    “Determined to understand medical papers, Kauffman struggled with jargon and slowly caught onto the tricks of the trade, such as incomplete and misleading abstracts.

    “The abstract of a paper is supposed to summarize the purpose, choice of subjects, trial protocol, and results.


    When Abstracts Are Incomplete, This Information is Left Out of Media Stories

    When abstracts do not mention all-cause mortality and side-effects, the media never does not include this in their coverage

    “When key results are left out of the abstract, such as all-cause mortality and side-effects, they remain left out of any press release, newspaper article and sales literature.


    When The Whole Paper Is Examined, Shocking Cover Ups Come To Light

    When the whole paper is examined, shocking cover ups come to light such as excess cancer deaths

    He continues, saying:

    “When the whole paper is examined, shocking cover ups come to light, in many cases, such as excess cancer deaths even when some easily measurable stuff, like cholesterol, is lowered, which is supposed to be a benefit, but is not.

    “People who would most benefit from a diet intervention are often excluded from the chosen subjects.


    High Dropout Rates Often Left Out of Abstracts

    Very high dropout rates due to drug side-effects usually left out of abstracts

    “Very high dropout rates because of treatment side-effects usually do not find their way to the abstract.



    This myth his from an article by Kauffman

    This medical myth is from an article by Joel Kauffman posted on the very interesting website SpaceDoc.com in an article titled Malignant Medical Myths in which he briefly describes the eleven (11) medical myths he writes about in his book.


    Other Kauffman articles

    Other Kauffman articles are posted here

    Other articles by Joel Kauffman, PhD are posted here:


    Joel M. Kauffman, PhD
    Professor of Chemistry Emeritus
    University of the Sciences of Philadelphia
    65 Meadowbrook Rd
    Wayne, PA 19087-2510 USA
    .(JavaScript must be enabled to view this email address)
    (215) 596-8839 phone


    About Kauffmann

    About Joel Kauffman, PhD

    Joel Kauffman, PhD is Professor of Chemistry Emeritus from the University of the Sciences of Philadelphia, Pennsylvania.


    Articles on the same subject can be found here:


    Please feel free to share your comments about this article.




    Please enter the word you see in the image below:

    Remember my personal information

    Notify me of follow-up comments?

    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.